“Pidotimod in paucisymptomatic SARS-CoV2 infected patients: Pidotimod in COVID-19” (2020) Mediterranean Journal of Hematology and Infectious Diseases, 12(1), p. e2020048. doi:10.4084/mjhid.2020.048.